Put Options

11 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024

BUY
$4.93 - $9.31 $986 - $1,862
200 Added 200.0%
300 $1,000
Q4 2023

Feb 14, 2024

SELL
$7.13 - $9.49 $1,426 - $1,898
-200 Reduced 66.67%
100 $0
Q3 2023

Nov 14, 2023

BUY
$7.77 - $12.27 $2,331 - $3,681
300 New
300 $2,000
Q1 2023

May 15, 2023

BUY
$5.94 - $11.27 $4,752 - $9,016
800 New
800 $8,000
Q3 2022

Nov 14, 2022

BUY
$6.66 - $12.39 $8,658 - $16,107
1,300 New
1,300 $10,000
Q1 2022

May 16, 2022

SELL
$10.05 - $22.48 $79,395 - $177,592
-7,900 Reduced 88.76%
1,000 $12,000
Q3 2021

Nov 15, 2021

BUY
$10.93 - $23.55 $44,813 - $96,555
4,100 Added 85.42%
8,900 $197,000
Q2 2021

Aug 16, 2021

BUY
$10.0 - $14.52 $28,000 - $40,656
2,800 Added 140.0%
4,800 $62,000
Q1 2021

May 17, 2021

SELL
$12.3 - $18.73 $119,310 - $181,681
-9,700 Reduced 82.91%
2,000 $26,000
Q4 2019

Feb 14, 2020

BUY
$3.88 - $21.42 $6,596 - $36,414
1,700 Added 17.0%
11,700 $237,000
Q3 2019

Nov 14, 2019

BUY
$5.34 - $6.59 $53,400 - $65,900
10,000 New
10,000 $53,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.15B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.